XtalPi, an Artificial Intelligence (AI) drug discovery and development technology company, announced today an oversubscribed Series C funding round of $318.8 million
Curi Bio launches Mantarray Platform for analysis of 3D engineered muscle tissue in the development of new therapeutics
Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors. The funds will be invested to continue building Recursion’s AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology. Recursion […]
The Bill and Melinda Gates Foundation and WuXi AppTec’s Corporate Venture Fund have led an $85 million funding round into Schrödinger. The company produces a computational platform for drug discovery, which it also uses for its own research.